Catalyst Wire Dossier Catalyst Wire Dossier

Allogeneic hematopoietic stem cell transplantation with TCRab+ T-cell and CD19+ B-cell depletion

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Allogeneic hematopoietic stem cell transplantation with TCRab+ T-cell and CD19+ B-cell depletion, covering 2025-05-23 to 2025-05-23. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1b/2a Trial of Allogeneic HSCT From an HLA-partially Matched Related or Unrelated Donor After TCRab+ T-cell/CD19+ B-cell Depletion for Patients With Monogenic and/or Early-onset Medically Refractory Crohn Disease [Phase 1, Phase 2]

See pricing